Clinical Trial Update: Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) Infection in Liver Transplant Candidates (EZE-2) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating ezetimibe for chronic hepatitis C in liver transplant candidates; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• EZETIMIBE (EZETIMIBE)

Snippet

Sponsor: Pontificia Universidad Catolica de Chile | Conditions: Hepatitis C | Phase 4 | Status: UNKNOWN